In cancer patients who have compromised immune systems, T-cell activator provides protection against coronaviruses.

Published Date: 30 Aug 2023

For individuals with inherited or congenital immunodeficiency, there is good news: The outcomes of a clinical phase II study at the University Hospital Tübingen directed by Prof. Dr. Juliane Walz and Prof. Dr. Helmut Salih exhibits effectiveness.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot